Inhalation Technology Trends: The Future of Inhalation

Due to the changes in technology in the inhalation space, the pharmaceutical industry is going to start to see some changes.

Our very own Director of Inhalation Science and Product Development at Recipharm, Lei Mao, spoke with Manufacturing Chemist about the current innovations in the inhaled drugs market. 

Since the launch of the first metred dose inhalers (MDIs) and dry powder inhalers (DPIs) in the twentieth century, the inhalation space in pharma has advanced dramatically. Inhalation as a drug delivery method is very different now, to what it used to be. The changes in inhalation sciences has generated large volumes of patient-centric products that are used in the treatment of several respiratory diseases. Inhalation is best known for its ability to deliver medicines directly to the patient’s respiratory system. 

Due to the changes in technology in the inhalation space, the pharmaceutical industry is going to start to see some changes. Respiratory diseases will always remain the main target of inhalation therapy, but we will start to see a growing interest in the use of inhalation dosage forms to target systemic delivery. Generally, the delivery of both small and large molecules into the lung leads to high absorption rates, making inhalation delivery attractive for drugs with a rapid onset of action.

To keep up with this change, more inhalers will be designed that offer better delivery efficiency. At Recipharm, we have also seen more portable nebulisers under development and vaporised inhalers, which could offer further advantages for both patients and developers. In addition to this, there will be an increased focus on enhancing the user-friendliness of devices using human factor engineering will also be key, as well as the introduction of more environmentally friendly propellants.

It is important that companies explore ways to make inhalers more affordable to patients by supporting the development of new products and generic alternatives that can reduce overall healthcare costs.

Read the full article here.